CPHI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Home Bortezomib Injection 3.5 mg vial DCP application
News
26 Apr 2021

Bortezomib Injection 3.5 mg vial DCP application

 

Onko Koçsel is proud that Bortezomib Injection 3.5 mg vial DCP application has been successfully accepted by EMA member countries on March, 2021. Onko Koçsel is open for collaboration within and outside EU countries.

Read more
Mentioned Companies
Onko Ilac Sanayi ve Ticaret A.S.
View company profile